{"nct_id":"NCT00124189","title":"Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)","status":"COMPLETED","status_verified_date":"2015-12","start_date":"2005-07","start_date_type":null,"primary_completion_date":"2013-03","primary_completion_date_type":"ACTUAL","completion_date":"2013-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GERN"]}